ono 1078 has been researched along with Lung Neoplasms in 2 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, CH | 1 |
| Song, SY | 1 |
| Kim, YD | 1 |
| Nakano, R | 1 |
| Oka, M | 1 |
| Nakamura, T | 1 |
| Fukuda, M | 1 |
| Kawabata, S | 1 |
| Terashi, K | 1 |
| Tsukamoto, K | 1 |
| Noguchi, Y | 1 |
| Soda, H | 1 |
| Kohno, S | 1 |
2 other studies available for ono 1078 and Lung Neoplasms
| Article | Year |
|---|---|
The inhibitory effect of the leukotriene receptor antagonist on leukotriene D4-induced MUC2/5AC gene expression and mucin secretion in human airway epithelial cells.
Topics: Carcinoma, Mucoepidermoid; Cell Line, Tumor; Chromones; Down-Regulation; Gene Expression; Humans; Le | 2007 |
A leukotriene receptor antagonist, ONO-1078, modulates drug sensitivity and leukotriene C4 efflux in lung cancer cells expressing multidrug resistance protein.
Topics: Adenocarcinoma; ATP-Binding Cassette Transporters; Carcinoma, Squamous Cell; Chromones; Dose-Respons | 1998 |